RedHill Biopharma's Opaganib Inhibits COVID-19 Variants in Preclinical Study
Go back to RedHill Biopharma's Opaganib Inhibits COVID-19 Variants in Preclinical Study| REDHILL BIO SP ADS (NASDAQ: RDHL) | Delayed: 0.63 +0.01 (1.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.62 | 52 Week High | $16.54 | |||
| Open | $0.60 | 52 Week Low | $8.10 | |||
| Day High | $0.63 | P/E | N/A | |||
| Day Low | $0.59 | EPS | $0.00 | |||
| Volume | 35,784 | |||||
| Redhill Biopharma Ltd, Ramat Gan (AMEX: REDIF) | Delayed: 0.67 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.67 | 52 Week High | $1.45 | |||
| Open | $1.10 | 52 Week Low | $1.15 | |||
| Day High | $0.67 | P/E | N/A | |||
| Day Low | $0.67 | EPS | $0.00 | |||
| Volume | 3,842 | |||||
